The model can be used to assess the effects of other commonly-prescribed medications, such as blockers of the angiotensin II system, on kidney function in diabetes, and to assess the extent to which those effects translate to a kidney with reduced nephron number and impaired function. Here, AGT is linked to diabetes mellitus.